Industries
Life sciences
Life sciences is in constant evolution, strongly fueled by advancements in ML and generative AI. We see several key trends driving change across research, pharma, biotech, biopharma, supply chain, manufacturing, and clinical services.
Innovate with AI and machine learning
To be competitive, organizations are investing in flexible, compliant data foundations that enable AI for table stakes and enterprise use cases.
Realize the future of sales and experience
Organizations are adapting digital experiences, education, and technologies. The sales rep role requires AI-supported sales tools, predictive analytics, automation, IoT connectivity, and more.
Navigate M&A complexity
M&A is on the rise, with more dynamic deal structures. Effective integration of data, platforms, and technology following mergers and acquisitions is crucial for maximizing value.
Optimize the supply chain with generative AI
GenAI can enhance operational efficiency, reduce carbon footprint, and improve cost management. It refines clinical trial processes, reduces waste, and enhances demand-supply planning accuracy.
Meet demand for personalized medicine and biotech
Personalized medicine is expected to hit $62.5B by 2032, which indicates a shift toward tailored treatments. Next-gen therapies that address a disease’s root causes are at the forefront.
Increase health equity
To accelerate global health equity, organizations can apply data-driven insights, partner with advocacy groups, foster internal alignment for implementation, and leverage the power of innovative technology.
2024 Slalom industry outlook: Life sciences
Our expertise in life sciences
Fast-track products from concept to market, minimizing risks in development. Get immediate value from GenAI for efficiency, clinical trials, and reporting.
Create a more resilient and compliant supply chain and establish more accurate demand and supply planning.
Support efforts in R&D and clinical trials by making use of AI, leveraging data assets, and developing innovative procurement workflows.
Scientists and practitioners are collaborating to drive drug
discovery and commercial strategies and deliver high-quality, complete,
and well-documented data.
Tomorrow’s life sciences technology landscape
HOLOGIC × INTELLIGENT PRODUCTS
Detecting cervical cancer with ML for earlier treatment
Hologic is working to make life-saving cervical cancer screening faster, more accurate, and available to anyone around the world. Slalom Build helped bring this intelligent healthcare solution to life with ~70% sensitivity compared to human review.
CUSTOMER SUCCESS HIGHLIGHTS
RESEARCH & CLINICAL SERVICES
1st
Approved by FDA
Hologic Genius™ is the first and only FDA-cleared digital cytology platform.
RESEARCH & CLINICAL SERVICES
28%
Reduction in false negatives
The Hologic Cervical AI algorithm improves sensitivity without decreasing specificity.
DISTRIBUTION
10%
Increase in confidence rate
A Veripad model identifies counterfeit medications with 5-10% higher confidence than humans.
Our thinking in life sciences
How Intelligent Products can rehumanize life sciences
More personalized care with wider reach. Sounds like a paradox, but it’s achievable today. Operationalized AI in the form of Intelligent Products delivers more successful clinical trials, faster diagnoses, and better precision medicine.
Our Technology Partners
The industry’s best technology partnerships
Our partnerships with over 700 of the world’s leading technology providers help us fuel innovation and sustainable growth for our customers.